NLRP3-IN-8 (compound 27), an orally active NLRP3 inflammasome inhibitor, directly binds to its target with an IC50 of 1.23 µM for IL-1beta inhibition. It demonstrates robust metabolic stability in liver microsomes (t1/2 = 138.63 min) and exhibits minimal toxicity (against L02: IC50 > 100 µM) [1].
Molekulargewicht:
420.41
CAS Nummer:
[2768650-56-0]
Formel:
C23H20N2O6
Target-Kategorie:
Others|||NOD-like Receptor (NLR)
T62221
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten